EUVIMEDEUVIMED entdecken
Open Access

A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice

Jingwen Yang, Haichun Pan, Katsuhiko Sekimata, Charles Hwang, Anshul Kulkarni, Hannah Thomas, Jade Lindenau, Tyler Duford, Hiroki Ueharu, Akiko Tanaka, Naoki Sakai, Mikako Shirouzu und 4 weitere

Bone · 2025

DOI: 10.1016/j.bone.2025.117565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2025. Verfasst von Jingwen Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Ossification, Heterotopic, Protein Kinase Inhibitors, Bone Morphogenetic Protein Receptors, Type I. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCRR NIH HHS, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ossification, HeterotopicProtein Kinase InhibitorsBone Morphogenetic Protein Receptors, Type IAnimalsAdministration, OralMiceMyositis OssificansMice, TransgenicActivin Receptors, Type ISignal TransductionHumans

Stichwörter der Autor:innen

Disease preventionGenetically induced heterotopic ossificationNovel BMP type 1 receptor kinaseinhibitor RK783Oral Administration

Substanzen

Protein Kinase InhibitorsActivin Receptors, Type IBone Morphogenetic Protein Receptors, Type IAcvr1 protein, mouse

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology, Wuhan Univ…
  • Department of Biologic and Materials Sciences & Prosthodontics, University of Michigan School of Dentistry, 1010 N. University Ave, Ann Arbor, MI, 48179, USA.
  • Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
  • Center for Organogenesis, Regeneration & Trauma, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Universi…
  • Drug Discovery Structural Biology Platform Unit, RIKEN Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
  • RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN TRIP Headquarters, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.

Förderung

  • NIAMS NIH HHS
  • NCRR NIH HHS
  • Japan Agency for Medical Research and Development
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • National Center for Research Resources
  • School of Dentistry, University of Michigan
  • University of Michigan

Zitieren

APA

Yang, J., Pan, H., Sekimata, K., Hwang, C., Kulkarni, A., Thomas, H., Lindenau, J., Duford, T., Ueharu, H., Tanaka, A., Sakai, N., Shirouzu, M., Hashizume, Y., Levi, B., Koyama, H., & Mishina, Y. (2025). A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice. Bone. https://doi.org/10.1016/j.bone.2025.117565

Vancouver

Yang J, Pan H, Sekimata K, Hwang C, Kulkarni A, Thomas H, et al. A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice. Bone. 2025. doi:10.1016/j.bone.2025.117565

BibTeX
@article{Yang2025,
  author = {Yang, Jingwen and Pan, Haichun and Sekimata, Katsuhiko and Hwang, Charles and Kulkarni, Anshul and Thomas, Hannah and Lindenau, Jade and Duford, Tyler and Ueharu, Hiroki and Tanaka, Akiko and Sakai, Naoki and Shirouzu, Mikako and Hashizume, Yoshinobu and Levi, Benjamin and Koyama, Hiroo and Mishina, Yuji},
  title = {A new BMP type 1 receptor kinase inhibitor for safe and efficient oral treatment to prevent genetically induced heterotopic ossification in mice},
  journal = {Bone},
  year = {2025},
  doi = {10.1016/j.bone.2025.117565}
}
Kostenlos starten →